HBV RNA in serum is an early predictor for sustained immune control following treatment with pegylated interferon alfa in patients with HBeAg negative chronic hepatitis B

Yazar
Hansen, B.
Tabak, F.
Feld, J.
Janssen, H.
Cakaloglu, Y.
Farag, M.
Campenhout, M. V.
van Boemmel, F.
Rijckborst, V.
Ferenci, P.
Üst veri
Tüm öğe kaydını göster
Bağlantı
http://hdl.handle.net/20.500.12627/42933
https://doi.org/10.1016/s0168-8278(18)31269-8
Koleksiyonlar